Oxidative dimer formation is the critical rate-limiting step for Parkinson's disease α-synuclein fibrillogenesis

被引:158
作者
Krishnan, S
Chi, EY
Wood, SJ
Kendrick, BS
Li, C
Garzon-Rodriguez, W
Wypych, J
Randolph, TW
Narhi, LO
Biere, AL
Citron, M
Carpenter, JF [1 ]
机构
[1] Univ Colorado, Hlth Sci Ctr, Dept Pharmaceut Sci, Sch Pharm, Denver, CO 80262 USA
[2] Univ Colorado, Dept Chem Engn, Boulder, CO 80309 USA
[3] Amgen Inc, Thousand Oaks, CA 91320 USA
关键词
D O I
10.1021/bi026528t
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Intraneuronal deposition of alpha-synuclein as fibrils and oxidative stress are both implicated in the pathogenesis of Parkinson's disease. We found that the critical rate-limiting step in nucleation of alpha-synuclein fibrils under physiological conditions is the oxidative formation and accumulation of a dimeric, dityrosine cross-linked prenucleus. Dimer formation is accelerated for the pathogenic A30P and A53T mutant alpha-synucleins, because of their greater propensity to self-interact, which is reflected in the smaller values of the osmotic second virial coefficient compared to that of wild-type synuclein. Our finding that oxidation is an essential step in alpha-synuclein aggregation supports a mechanism of Parkinson's disease pathogenesis in which the separately studied pathogenic factors of oxidative stress and alpha-synuclein aggregation converge at the critical step of alpha-synuclein dimer formation.
引用
收藏
页码:829 / 837
页数:9
相关论文
共 62 条
[1]   MONITORING OF PROTEIN CONFORMATION BY HIGH-PERFORMANCE SIZE-EXCLUSION LIQUID-CHROMATOGRAPHY AND SCANNING DIODE-ARRAY 2ND-DERIVATIVE UV ABSORPTION-SPECTROSCOPY [J].
ACKLAND, CE ;
BERNDT, WG ;
FREZZA, JE ;
LANDGRAF, BE ;
PRITCHARD, KW ;
CIARDELLI, TL .
JOURNAL OF CHROMATOGRAPHY, 1991, 540 (1-2) :187-198
[2]  
AMADO R, 1984, METHOD ENZYMOL, V107, P377
[3]   AGING, ENERGY, AND OXIDATIVE STRESS IN NEURODEGENERATIVE DISEASES [J].
BEAL, MF .
ANNALS OF NEUROLOGY, 1995, 38 (03) :357-366
[4]  
Beckman JS, 1996, AM J PHYSIOL-CELL PH, V271, pC1424
[5]   Mutational effects on inclusion body formation [J].
Betts, S ;
HaasePettingell, C ;
King, J .
ADVANCES IN PROTEIN CHEMISTRY, VOL 50: PROTEIN MISASSEMBLY, 1997, 50 :243-264
[6]   Residual structure and dynamics in Parkinson's disease-associated mutants of α-synuclein [J].
Bussell, R ;
Eliezer, D .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (49) :45996-46003
[7]   Brain protein oxidation in age-related neurodegenerative disorders that are associated with aggregated proteins [J].
Butterfield, DA ;
Kanski, J .
MECHANISMS OF AGEING AND DEVELOPMENT, 2001, 122 (09) :945-962
[8]  
Chang RC, 2000, PROTEINS, V41, P123, DOI 10.1002/1097-0134(20001001)41:1<123::AID-PROT140>3.0.CO
[9]  
2-Q
[10]   Fibrils formed in vitro from α-synuclein and two mutant forms linked to Parkinson's disease are typical amyloid [J].
Conway, KA ;
Harper, JD ;
Lansbury, PT .
BIOCHEMISTRY, 2000, 39 (10) :2552-2563